5DZIK W H. Leukoreduction of blood component [ J ]. Curr Opin Hematol, 2002,9 (6) :521-526.
6GOODNOUGH L T, BRECHER M E, KANTER M H, et al. Transfusion medrcine. First of two parts-blood transfusion [J]. N Engl J Med, 1999,340(6) :438-447.
7The administration of blood and blood components and the management of transfused patients. British Committee for Standards in Haematology, Blood Transfusion Task Force. Royal College of Nursing and the Royal College of Surgeons of England[J]. Transfus Med, 1999, 9(3):227-228.
8NERI R A, MASON C E, DEMKO L A. Application of Six Sigma/CAP methodology: controlling blood-product utilization and costs [ J ]. J Healthc Manag, 2008,53 (3) : 183-195.
9American Society of Anesthesiologists Task Force on Periop- erative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies : an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant therapise [ J ]. Anesthesiology, 2006,105 ( 1 ) : 198-208.
10O'SHAUGHNESSY D F, ATTERBURY C, BOLTON MAGGS P, et al. Guidelines for the use of fresh-frozen plas- ma, cryoprecipitate and cryosupernatant[ J ]. Br J Haematol, 2004,126(1) :11-28.
